EIKO Lifesciences opened higher at ₹49.50, compared with its previous close of ₹48.39. In the last trading session on 12 Nov 2026, the stock traded between ₹48.00 and ₹49.50, with an average traded price of ₹48.24. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in EIKO Lifesciences is now worth
₹ 6,846.00
Resulting in a loss of
₹ 3,154.00 (31.54%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.35 (+0.72%)
Day High
₹49.50
Day Low
₹48.00
Day Open
₹49.50
Prev Close
₹48.39
Volume
6,905
Value Traded
₹0.03 Cr
1W Return
-4.07%
1M Return
4.48%
3M Return
-2.25%
6M Return
-1.30%
1Y Return
-10.83%
Market Cap (₹ Cr.)
71
PE Ratio
11.80
PB Ratio
0.98
Dividend Yield
-
ROE
7.63%
ROCE
10.07%
Book Value (₹)
49.62
Face Value (₹)
10.00
EPS (TTM)
0.93
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-4.07%
6 Weeks
-
1 Month
4.48%
3 Months
-2.25%
9 Months
-5.41%
Eiko Lifesciences Q2FY27 net profit up 36%; forms renewable energy JV
Net profit rose 36% YoY to ₹156.37 lakh in Q2FY27. Revenue from operations increased 52% YoY to ₹1,772.02 lakh. Subsidiary Eiko Scientific Solutions LLP formed a 50-50 JV with Oval Projects Engineering Limited. New entity Oval Eiko Resources Private Limited will focus on compressed bio-gas production. Initial capital for the joint venture is set at ₹2,50,000.
7 days agoEiko Lifesciences promoter group stake rises to 18.18% after warrant conversion
Lenus Finvest Private Limited acquired 1,50,000 equity shares of Eiko Lifesciences via warrant conversion. Promoter group holding in Eiko Lifesciences rises to 18.18% of total issued capital. Transaction occurred on October 16, 2026, through preferential allotment conversion. Total equity share capital of Eiko Lifesciences increased to 14,80,08,540 shares.
25 days agoEiko Lifesciences AGM resolutions pass with majority; voting details out
All four AGM resolutions passed with requisite majority on September 22, 2026. Promoter votes excluded from director re-appointment and related party transaction approvals. Suraj Mahadev Gaikwad appointed as Independent Director via special resolution. FY26 standalone and consolidated financial statements adopted by shareholders.
1mo agoEiko Lifesciences files FY26 annual report, sets Sept 22 AGM
Eiko Lifesciences files FY26 annual report and confirms AGM on September 22, 2026. Suraj Mahadev Gaikwad appointed as additional independent director; Hasti Doshi resigns. Shareholders to approve related-party transactions up to ₹50 crore with associates and subsidiaries.
2mo agoEiko Lifesciences accepts Hasti Doshi's resignation as independent director
Eiko Lifesciences accepted Hasti Doshi's resignation as Independent Director. Effective date is August 24, 2026, citing other career commitments. Her term was originally set to end on September 3, 2029. She holds no directorships in other listed entities.
2mo agoEiko Lifesciences disputes IDBI Bank's ₹58 lakh guarantee claim from 1986
Eiko Lifesciences Limited disputes IDBI Bank's recovery proceedings over an alleged ₹58 lakh corporate guarantee from 1986. The guarantee was supposedly issued by erstwhile entity Narendra Investments (Delhi) Limited for Consolidated Steels & Alloys Limited. The company denies liability, citing the historical nature of the claim, and asserts no material financial impact is expected while pursuing legal remedies.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹19,389.00 | +0.59% | ₹1,75,451.17 | 74.40 | +37.67% | |
| ₹1,545.20 | -2.18% | ₹1,57,282.77 | 59.10 | +4.26% | |
| ₹2,468.00 | -0.36% | ₹73,157.65 | 32.30 | -16.09% | |
| ₹6,849.00 | +0.65% | ₹58,411.16 | 117.40 | +18.07% | |
| ₹4,767.10 | -0.97% | ₹52,366.59 | 79.80 | +28.86% | |
| ₹10,102.00 | +1.33% | ₹51,815.56 | 56.20 | +67.74% | |
| ₹558.75 | -0.68% | ₹28,193.08 | 33.00 | +21.52% | |
| ₹1,670.20 | -1.14% | ₹22,168.20 | 89.90 | +124.59% | |
| ₹1,602.00 | -1.43% | ₹21,850.17 | 20.90 | -7.18% | |
| ₹483.00 | -0.19% | ₹17,513.31 | 29.60 | +21.63% | |
| ₹5,338.00 | +0.10% | ₹16,366.30 | 34.00 | +25.03% | |
| ₹1,243.90 | -1.12% | ₹15,702.72 | 16.10 | -10.72% |
An investment of ₹10,000 made 5 years ago in EIKO Lifesciences is now worth
₹ 6,846.00
Resulting in a loss of
₹ 3,154.00 (31.54%)
Note: Past profits do not guarantee future returns.
